In pursuit of candidate/lead molecules for oral cancer, it is hypothesized that chemical entities inhibiting the overexpression of Akt1 and Akt2 without suppressing the expression of MAOB may demonstrate promising therapeutic potential. The gene discussed is AKT1; the disease is lip and oral cavity carcinoma.